Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves Outcomes in Pretreated Patients with Metastatic Cancer By Ogkologos - October 14, 2025 182 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ROME study Source RELATED ARTICLESMORE FROM AUTHOR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma EMA Recommends Extension of Therapeutic Indications for Retifanlimab MOST POPULAR Plasma-Based, Tumour-Informed MRD Analysis May Predict Recurrence During Adjuvant Osimertinib and... April 2, 2025 EMA Recommends Granting a Marketing Authorisation for Lenalidomide Mylan October 23, 2020 Obesity May Help Tumors Survive and Grow, Mouse Study Suggests January 22, 2021 NCI-MATCH Update: More Labs, New Arms, and Initial Findings November 15, 2018 Load more HOT NEWS UK sunburn risk: Third of adults more likely to protect their... Elucidating a Risk of Developing Second Primary Malignancy During and After... Whole- and Partial-Breast Radiation Effective at Preventing Breast Cancer from Returning The Evidence Is In: COVID Vaccines Do Protect Patients With Cancer...
